Andrew Balo

Andrew Balo

Chief Tech/Sci/R&D Officer at DEXCOM, INC.

Net worth: 11 M $ as of 2024-03-30

76 year
Health Technology
Consumer Services

Profile

Mr. Andrew K. Balo is an EVP-Clinical Affairs, Regulatory Strategy at DexCom, Inc. Mr. Balo was previously employed as a Vice President-Regulatory & Clinical Affairs by InnerCool Therapies, Inc., a VP-Quality, Regulatory & Clinical Affairs by St. Jude Medical LLC, and a Vice President-Rgulatory & Clinical Affairs by Endocardial Solutions, Inc. He received his undergraduate degree from the University of Maryland.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-03-09 81,120 ( 0.02% ) 11 M $ 2024-03-30

Andrew Balo active positions

CompaniesPositionStart
DEXCOM, INC. Chief Tech/Sci/R&D Officer 2002-01-31
All active positions of Andrew Balo

Former positions of Andrew Balo

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 2002-01-31
ST JUDE MEDICAL INC Chief Tech/Sci/R&D Officer 1996-12-31
Chief Tech/Sci/R&D Officer -
See the detail of Andrew Balo's experience

Training of Andrew Balo

University of Maryland Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew Balo's experience

Connections

92

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
DEXCOM, INC.

Health Technology

Private companies3

Health Technology

Health Technology

Health Technology

See company connections